| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $313K | — | -60.1% |
| Cost of Revenue | $600K | — | -32.4% |
| R&D Expense | $2.1M | — | -36.6% |
| SG&A Expense | $6.6M | — | +101.6% |
| Operating Income | -$8.9M | — | -27.1% |
| Net Income | -$9.4M | — | -3.2% |
| EPS (Basic) | -$0.14 | — | +62.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $53.0M | +212.5% | +1255.8% |
| Accounts Receivable | $312K | -75.8% | -91.4% |
| Current Assets | $77.0M | +272.6% | +390.3% |
| Total Assets | $218.1M | +28.6% | +95.9% |
| Current Liabilities | $17.1M | +70.3% | +98.1% |
| Total Liabilities | $58.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.8M | — | -17.3% |
| Investing Cash Flow | -$14.5M | — | -700.1% |
| Financing Cash Flow | $56.4M | — | +479.3% |
| +12.7% |
| Stockholders' Equity | $156.4M | +45.4% | +162.7% |